General Mills Reports $4.5 Billion in Quarterly Sales
Publisher |
Barron's
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Sep 23, 2021
Episode Duration |
00:03:53
General Mills beats expectations. Biogen's latest drug disappoints. And a look at three newly public companies. Host: Shaina Mishkin. Producer: Katie Ferguson. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review